A new Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda has emerged as more than just another epidemiological episode in Central Africa. It has become a harsh indictment of the entire international health security system. In May 2026, the world once again witnessed what it preferred to ignore after COVID-19: the next major biological disaster will likely not be born in a sterile laboratory, an abstract "wet market," or a futurist scenario. It will emerge from a war zone - a place where hospitals are destroyed, doctors fear to speak, patients hide symptoms, armed groups control the roads, sanitary surveillance is reduced to a lottery, and trust in the state has long since died.
On May 17, 2026, the WHO declared the outbreak of the disease caused by the Bundibugyo virus a Public Health Emergency of International Concern. At that moment, official reports indicated eight laboratory-confirmed cases, 246 suspected cases, and 80 suspected deaths in the Ituri province of the DRC, along with confirmed cases in Kampala among individuals traveling from the Congo. The very first WHO documents identified key risk factors: armed instability, a humanitarian crisis, high population mobility, urban and semi-urban hubs, a network of informal healthcare facilities, and the absence of approved specific vaccines or therapeutics against Bundibugyo.
According to CDC data citing the ministries of health of the DRC and Uganda, the DRC had already recorded 904 suspected cases, 101 confirmed cases, 119 suspected deaths, and 10 confirmed deaths; Uganda reported five confirmed cases and one confirmed death. The CDC also reported that a new confirmed case emerged in South Kivu, whereas previous confirmations were limited to Ituri and North Kivu. This signifies more than just an increase in numbers. It marks the geographical expansion of the epidemic process in a region where controlling human movement, contact tracing, and the safe transport of patients are extremely difficult.
This Is Not an "African Problem" - It Is a Model for Future Pandemics
It is tempting to view this outbreak as a local tragedy in a remote region. This is a mistake. The DRC is not the periphery of global epidemiology; it is one of the nerve centers of global biosecurity. This is where forest ecosystems, zoonotic reservoirs, internal migration, illegal resource extraction, armed groups, ruined infrastructure, cross-border trade, and the chronic underfunding of healthcare intersect. Such an environment does not merely "host" viruses. It accelerates their detection too late, and sometimes, prevents detection altogether.
The Bundibugyo virus belongs to the orthoeabolaviruses. The incubation period of the disease can range from 2 to 21 days. A person infected with an orthoeabolavirus is not considered contagious until symptoms appear; transmission occurs through direct contact with blood, urine, feces, saliva, vomit, semen, other bodily fluids of a sick or deceased person, as well as through contaminated objects like needles. The CDC explicitly points out: Ebola virus disease does not spread through the air. This fundamentally distinguishes it from influenza or coronavirus infections.
Yet, this is precisely where the paradox lies. Ebola is not an ideal pandemic virus in the classical sense. It is not as easily transmitted as SARS-CoV-2 or influenza. It can be contained with early diagnosis, isolation, contact tracing, infection prevention, safe burials, and public trust. However, all these measures presuppose a functioning state, protected medical workers, logistics, laboratories, communications, fuel, personal protective equipment, a clear chain of command, and at least minimal trust between society and authority. In Ituri and neighboring districts, all of this is critically scarce.
Therefore, the new outbreak is significant not just on its own. It demonstrates that the danger of the 21st century lies not only in the biology of the pathogen, but also in the political ecology of its transmission. The same virus in a stable country and in a conflict zone represents two entirely different epidemiological events. In the first case, it meets a system. In the second, it meets ruins.
Bundibugyo: A Rare Strain, a Harsh Medical Reality
The primary medical challenge of the current outbreak is not only the lethality of Ebola, but the specific type of virus. Existing licensed tools against Ebola are primarily associated with the species Orthoebolavirus zairense, meaning the Zaire ebolavirus. Regarding Bundibugyo, the situation is significantly worse. The CDC indicates that there is no FDA-licensed or authorized vaccine in the United States to protect against Bundibugyo infection; the ERVEBO vaccine is designed to prevent disease caused by another species of ebolavirus and is not expected to protect against Bundibugyo. There is also no FDA-approved treatment specifically for the disease caused by Bundibugyo, though experimental approaches have shown efficacy in animal models.
This drastically alters the risk calculation. During previous major outbreaks of the Zaire variant, the world could already rely on ring vaccination, monoclonal antibodies, and accumulated clinical management experience. Now, medical workers are forced to return to a basic but extremely resource-intensive model: early diagnosis, intensive supportive care, rehydration, correction of electrolyte imbalances, shock management, control of hemorrhagic manifestations, staff protection, and strict infection prevention and control. With good intensive care, mortality can be reduced. But in hospitals lacking masks, gloves, IV fluids, oxygen, transportation, and trained personnel, even simple supportive care becomes an act of heroism.
The WHO estimates the average case fatality rate of Ebola virus disease at approximately 50 percent, with rates in past outbreaks ranging from 25 to 90 percent. This is not a single fixed figure but a range depending on the virus species, patient age, quality of early diagnosis, availability of fluid therapy, level of infection control, and the timing of medical intervention.
The history of Bundibugyo itself is also alarming. The CDC recalls two previous outbreaks of this virus: in Uganda in 2007 and in the DRC in 2012, where the case fatality rates were approximately 25 and 50 percent, respectively. In the current outbreak, the first identified clinical profiles included typical Ebola symptoms: fever, headache, vomiting, severe weakness, abdominal pain, nosebleeds, and vomiting blood.
Ituri Is Not Just the Location of the Outbreak - It Is the Ideal Epidemic Trap
Ituri province and the eastern regions of the DRC are not merely a geographical backdrop. They are an active epidemiological factor. Conflict, population displacement, destroyed settlements, illegal armed networks, a local survival economy, informal clinics, distrust of official medicine, and political fragmentation create an environment where every classic tool for fighting Ebola underperforms.
In humanitarian terms, the DRC remains one of the world's most severe crisis zones. The UN Humanitarian Response Plan for 2026 requires 1.4 billion euros to assist 14.9 million people. In the country, 26.6 million people face acute food insecurity, 5.8 million people remain internally displaced, and the total number of displaced persons is estimated at 8.2 million, with projections rising to 9 million by the end of 2026. More than 1.2 million Congolese are refugees in neighboring countries.
For a virus, this is an ideal transport network. People move not because they want to travel, but because they are fleeing. They escape fighting, search for food, move in with relatives, go to markets, cross informal borders, and spend the night in schools, churches, camps, hospital yards, and temporary shelters. In such a situation, a "contact" is not a neat line in an epidemiological questionnaire. It represents dozens of people whom no one has recorded, knows, or will ever be able to find.
This is precisely why border closures, panic-driven bans, and harsh transport measures often backfire. The WHO explicitly warns that countries should not close borders or impose travel and trade restrictions, because such measures are frequently based on fear, lack scientific justification, push the movement of people and goods into informal crossings, and can thereby increase the risk of the disease spreading.
When a Hospital Becomes an Amplifier of Infection
Ebola almost always exposes the vulnerabilities of a healthcare system. The first casualties among healthcare workers represent one of the most dangerous warning signs. Early in the current outbreak, the WHO reported at least four deaths among healthcare workers in a clinical context resembling viral hemorrhagic fever. This points to potential nosocomial transmission, failures in infection control, and the risk of the epidemic amplifying within healthcare facilities themselves.
In a functioning system, a hospital should be a place where a virus is contained. In a shattered system, it can become an accelerator. A single patient with hemorrhagic fever entering a crowded ward without triage, without isolation, without PPE, without a trained nursing team, and without a clear protocol for handling bodily fluids is capable of infecting staff, other patients, relatives, and orderlies. Consequently, the hospital is transformed from a center of care into a center of fear.
This has happened before. The 2018–2020 Ebola outbreak in North Kivu and Ituri was one of the largest in the history of the DRC. It unfolded amidst violence, armed groups, rumors, and attacks on medical facilities. Back then, medical workers faced not only the virus but also direct assaults, the burning of treatment centers, threats, and resistance from local communities. The current outbreak is developing in a region where the memory of those events has not faded.
Violence against healthcare has become one of the primary epidemiological threats today. In 2024, according to the Safeguarding Health in Conflict Coalition, 3,623 incidents against healthcare were recorded in armed conflicts - a 15 percent increase from 2023 and a 62 percent increase from 2022. This is not a statistical detail but a fundamental shift: hospitals are increasingly ceasing to be neutral spaces and are becoming wartime targets.
Funerals, Rumors, and Trust: Epidemiology Does Not Begin in the Lab
One of the most painful aspects of Ebola is burials. The bodies of those who die from Ebola remain highly contagious, as contact with bodily fluids during traditional funeral practices can trigger new chains of transmission. Yet, for local communities, a funeral is not a technical procedure; it is a sacred, familial, and social act. When authorities ban wakes, restrict access to bodies, and hand over burials to specialized teams, people often perceive this not as protection, but as an insult, an act of violence, and the theft of a final right.
In May 2026, authorities in Ituri already banned funeral wakes and introduced strict measures following clashes over burial practices. Nearly 750 suspected cases and 177 deaths had been reported at the time of these measures, with the WHO pointing to late detection, the lack of specific therapeutics, ongoing violence, and high population mobility as key risk factors.
This is real epidemiology. It consists not only of R0, PCR, sequencing, and contact maps. It consists of fear, rumors, memories of violence, local authorities, religious leaders, family obligations, market economics, and a distrust of people in protective suits. If the population believes that a hospital is a place where a person is taken to die, they will hide the sick. If a safe burial is perceived as political violence, families will resist. If contact tracers are associated with informants, people will lie.
The WHO therefore demands not just laboratories and isolation wards, but broad community engagement - through local, religious, and traditional leaders, including healers. This is not a diplomatic formality. It is a matter of survival for the anti-epidemic operation.
The Technological Illusion: Why Vaccines Do Not Save Without a State
Following COVID-19, the global elite bet on the technological containment of pandemics: platform vaccines, sequencing, artificial intelligence, biosurveillance, databases, rapid tests, and medical countermeasures. All of this is necessary. However, the current outbreak demonstrates the limits of this approach. Technology cannot substitute for trust, logistics, security, and state capacity.
A vaccine can be developed, but it must be delivered to an area where roads are controlled by armed groups. A test can be created, but a sample must be safely collected, packaged, transported, and processed. A contact list can be compiled, but the contact must agree to speak. A treatment center can be opened, but the staff must be protected from both the virus and armed attacks. A protocol can be written, but it is useless if the clinic lacks gloves and fuel for a motorcycle.
The WHO, at the World Health Assembly in May 2026, effectively acknowledged this problem: negotiations on the annex concerning pathogen access and benefit-sharing within the Pandemic Agreement were extended. This annex is critical for opening the agreement for signature, and member states must present the outcome either at a special session in 2026 or at the Assembly in May 2027.
Yet, the dispute over pathogens, vaccines, samples, and benefits is only part of the picture. If a future pandemic emerges in a war zone, the question will not just be who gets access to the genome sequence and vaccine licenses. The question will be who even finds out about the outbreak when a doctor is afraid to send a message, the lab is non-functional, roads are cut off, patients are displaced, and the hospital is caught between front lines.
Global Healthcare in an Era of Budget Cuts
The new Ebola outbreak coincides with a drastic shift in the architecture of international aid. In 2025, the US administration under President Trump froze and reviewed significant volumes of foreign assistance, and the elimination of USAID along with the transition to new funding mechanisms has already impacted partners engaged in the prevention and detection of infectious diseases. KFF notes that partner organizations reported staff layoffs and the termination of many disease prevention and detection activities, including Ebola-related programs in Uganda and the DRC.
The US, according to KFF data, mobilized 23 million dollars in emergency funding to support response efforts in the DRC and Uganda. At the same time, however, the new aid model provides for five-year agreements with the DRC and Uganda, with the volume of promised funding for the next five years being 27 percent lower than during the previous five-year period. This means the world is entering a new era: threats are becoming more complex, while sustainable response mechanisms are becoming more fragile.
This is not abstract bureaucracy. Epidemiological readiness means people on the ground. It means laboratory technicians, nurses, drivers, infection control specialists, community communication experts, logisticians, and field epidemiologists. When funding is cut, what disappears is not "projects," but the specific eyes and hands of the early warning system.
Ebola Is Only the Visible Fire: The Entire System Is Burning Around It
The current outbreak does not occur in a vacuum. In the DRC, other infectious and humanitarian crises are active simultaneously: cholera, measles, mpox, malaria, malnutrition, trauma, sexual violence, psychosocial collapse, and drug-resistant infections. The WHO, in its emergency appeal for the DRC for 2026, explicitly states that protracted conflict, recurrent disease outbreaks, and chronic underinvestment form one of the most complex health crises in the world; 7.5 million people, particularly in the eastern provinces, are in urgent need of health assistance.
Mpox has served as another warning. According to the WHO, from January 1, 2025, to January 18, 2026, 29 African countries reported 44,542 confirmed cases of mpox and 198 deaths. The DRC continued to be one of the main hotbeds, and the emergence of clade Ib introduced new risks of sustained human-to-human transmission.
Cholera exhibits the same pattern. According to the ECDC, from January 1 to March 23, 2026, the DRC registered 15,100 cholera cases and 395 deaths; during the period from February 18 to March 23 alone, 5,775 new cases and 176 new deaths were recorded. Cholera is a disease of water, sanitation, and ruined infrastructure. In a war zone, it becomes a marker of the collapse of basic urban and rural life.
Malaria remains another silent killer. The WHO World Malaria Report 2025 states that there were approximately 282 million malaria cases and 610,000 deaths globally in 2024, with the WHO African Region bearing the brunt of the burden. Conflicts, climate change, drug and insecticide resistance, and underfunding are creating conditions for a reversal of the progress achieved.
Finally, there is antimicrobial resistance. The WHO estimates that bacterial antimicrobial resistance directly caused 1.27 million deaths in 2019 and was associated with 4.95 million deaths. In conditions of ruined hospitals, chaotic antibiotic prescribing, poor sterilization, wounds, contaminated water, and a lack of laboratory control, AMR becomes a daily reality rather than a future threat.
The Next Pandemic Could Begin as an "Ordinary" Crisis in Someone Else's War
The primary flaw of the international system is the separation of humanitarian crises from pandemic readiness. In official reports, these exist in separate folders: here is the conflict, there is the epidemic; here is famine, there are vaccines; here are refugees, there is the laboratory network. In real life, this is a single interconnected process.
When water infrastructure is destroyed, cholera rises. When people flee to crowded camps, measles, mpox, tuberculosis, and acute respiratory infections surge. When hospitals are overwhelmed, nosocomial outbreaks emerge. When surgeons operate without sterile conditions, resistance escalates. When medical personnel flee or are killed, early detection vanishes. When armed groups control information, an outbreak becomes a political secret.
Polio serves as a distinct example of how political instability keeps legacy threats alive. The international spread of poliovirus was declared a Public Health Emergency of International Concern back on May 5, 2014, and this status has persisted for more than a decade.
This means that pandemic security is not merely a biomedical issue. It is an issue of war and peace, trust and authority, finance and infrastructure, borders and migration, information and fear. While international conferences discuss future vaccine platforms, actual pathogens exploit real-world vulnerabilities: ruined roads, impoverished hospitals, political violence, bureaucratic paralysis, and social trauma.
The World Prepares for the Virus, but Fails to Prepare for the Chaos
In May 2026, simultaneous with the Ebola situation, the world faced another signal - a cluster of infections caused by the Andes hantavirus linked to the cruise ship MV Hondius. The WHO reported that illnesses among passengers manifested between April 6 and April 28, presenting with fever, gastrointestinal symptoms, rapid progression to pneumonia, acute respiratory distress syndrome, and shock. The ECDC stated that passengers and crew from 23 countries, including EU and EEA nations, were on board.
This episode is important as a contrast. A cruise ship rapidly becomes the focus of international attention because it involves citizens of wealthy nations, insurance mechanisms, evacuations, diplomacy, aviation, and media visibility. Meanwhile, in Ituri, death can march for weeks through villages, markets, and informal clinics before the world ever sees a data chart. This is not an accusation, but the cold reality of global inequality: the visibility of an outbreak often depends not on its inherent danger, but on who it affects.
This selectivity is dangerous. The next major threat can easily look like someone else's local problem for a very long time. This is exactly how many global crises begin - with an event that is initially deemed peripheral, manageable, geographically distant, and politically inconvenient, and therefore unworthy of maximum attention.
What Needs to Be Done Differently
First, the international community must stop viewing conflict zones as a humanitarian appendix to global healthcare. They must be the central element of pandemic strategy. A robust early warning system must be constructed where the risk is highest, not just where it is easiest to operate.
Second, healthcare must be protected as an asset of international security. Attacks on hospitals, threats to doctors, the destruction of water infrastructure, the blocking of medical supplies, and targeting ambulances are not only violations of humanitarian law. They are the active manufacturing of epidemic risk.
Third, funding must target horizontal systems rather than exclusively vertical campaigns against specific pathogens. The world needs district-level laboratories, epidemiological teams, oxygen supply systems, infection control, personnel training, water supply, sanitation, cold chains, community communication, and reliable salaries for healthcare workers. Without this, even the most advanced vaccine remains a tool without a foundation.
Fourth, the meaning of "readiness" must be redefined. True readiness is not just vaccine stockpiles, sequencing algorithms, and airport screening protocols. True readiness is the ability of a doctor to report a suspected case without the fear of disappearing. It is the capacity of a community to trust a sanitary team. It is the ability of a patient to reach a clinic. It is the opportunity to bury the deceased safely, yet with respect. It is the capacity of a laboratory to function even when a war is raging around it.
Fifth, the illusion that wealthy countries can isolate themselves from the biological consequences of foreign wars must be abandoned. The CDC currently assesses the risk to the US population as low and reports no confirmed cases in the United States linked to this outbreak. This is important and reassuring. However, a low risk today does not mean the absence of a systemic threat tomorrow.
A Final Warning from Ituri
Ebola in the DRC and Uganda is more than just medical news. It is a political warning. The world has built a complex vocabulary of pandemic preparedness, but it remains remarkably blind to the places where pathogens find their best opportunities. A virus does not require an ideology. It only needs a ruined hospital, a refugee stream, untrained personnel, a lack of diagnostic tests, fear of authority, and a few weeks of silence.
The next pandemic will not necessarily begin with a loud announcement. It may begin as a few deaths among nurses, a strange fever following a funeral, a rumor of a "bloody disease," a closed clinic in an area inaccessible to humanitarian vehicles, or a report a doctor is too afraid to transmit.
This is precisely why Ituri today is not the periphery. It is a mirror of the future. The world can invest billions into biotechnology, but if it fails to learn how to protect medicine in war, rebuild trust in shattered societies, and fund basic healthcare systems where they are needed most, the next pandemic will arrive not because science was too late. It will arrive because politics once again chose not to see the obvious.